SNH-119014
/ ScinnoHub, Chengdu Brilliant Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 04, 2025
Snh-119014, a novel pyruvate kinase activator, enhances ATP production and reduces oxidative stress in erythroid cells from patients with β-thalassemia major
(ASH 2025)
- "SNH-119014 activates PK, increases ATP production, and alleviates oxidative stress inerythroid cells from β-TM patients. Its comparable efficacy to AG-348 in ex vivo systems supports SNH-119014 as a promising candidate for therapeutic development in thalassemia."
Clinical • Oxidative stress • Anemia • Beta-Thalassemia • Genetic Disorders • Hematological Disorders • CD34
1 to 1
Of
1
Go to page
1